Pliant Therapeutics Inc
Pliant Therapeutics Inc logo
PLRX

Pliant Therapeutics Inc (PLRX)

$18.385.84%

Market is closed
– opens on 8 PM, 01 Dec 2022
  • $

1D

1W

1M

1Y

3Y

5Y

Key Stats

$17.56
Day's Range
$19.58
$3.97
52-Week Range
$26.25
1 month return26.95%
3 month return9.46%
1 year return38.2%
5 year return13.71%

Company Information

Pliant Therapeutics is a clinical stage biopharmaceutical company focused on discovering and developing novel therapies for the treatment of fibrosis. Pliant's lead product candidate, PLN-74809, is an oral small-molecule dual selective inhibitor of avß6 and avß1 integrins that is in development for the treatment of idiopathic pulmonary fibrosis, or IPF, and primary sclerosing cholangitis, or PSC. PLN-74809 has received Orphan Drug Designation from the U.S. Food and Drug Administration for both IPF and PSC. Pliant is currently recruiting Phase 2a trials of PLN-74809 for the treatment of IPF and PSC. Pliant's second product candidate, PLN-1474, is a small-molecule selective inhibitor of avß1 for the treatment of liver fibrosis associated with nonalcoholic steatohepatitis, or NASH, which Pliant has partnered with Novartis. In addition to clinical stage programs, Pliant currently has two preclinical programs targeting oncology and muscular dystrophies.
OrganizationPliant Therapeutics Inc
Employees114
CEODr. Bernard Coulie M.B.A., M.D., MBA, Ph.D.
IndustryHealth Technology

Analyst Recommendation

based on 7 analysts ratings

Buy
100%
Buy
0%
Hold
0%
Sell

Based on 7 Wall street analysts offering stock ratings for Pliant Therapeutics Inc(by analysts ranked 0 to 5 stars)

Analyst Forecast

What analysts predicted

Upside of 133.35%

Current

$18.38

Target

$42.89

Recommendation Trend

Based on 7 analyst

Current1M Ago3M Ago
Buy
7
15
14
Hold
0
1
1
Sell
0
0
0
Consensus
BUY
BUY
BUY

Highlights

Market Capitalization
951.8M
Book Value
$6.91
Dividend Share
0.0
Dividend Yield
0.0%
Earnings Per Share (EPS)
-2.85
Wall Street Target Price
42.89

Valuation

Trailing PE0.0
Forward PE0.0
Price/Book (mrq)
2.84
Enterprise Value
614.6M
Enterprise Value/Revenue
63.23
Enterprise Value/Ebitda
-5.46

Technicals

Beta
1.26
50 Day MA
21.96
200 Day MA
14.05

Institutional Holdings

TRV GP III, LLC

11.98%

FMR Inc

6.86%

CHI Advisors LLC

6.37%

Redmile Group, LLC

6.3%

TRV GP IV, LLC

4.38%

Avidity Partners Management LP

4.06%

Discover more

Frequently Asked Questions

What is Pliant Therapeutics Inc share price today?

Can Indians buy Pliant Therapeutics Inc shares?

How can I buy Pliant Therapeutics Inc shares from India?

Can Fractional shares of Pliant Therapeutics Inc be purchased?

What are the documents required to start investing in Pliant Therapeutics Inc stocks?

What are today’s High and Low prices of Pliant Therapeutics Inc?

What are today’s traded volumes of Pliant Therapeutics Inc?

What is today’s market capitalisation of Pliant Therapeutics Inc?

What is the 52 Week High and Low Range of Pliant Therapeutics Inc?

How much percentage Pliant Therapeutics Inc is down from its 52 Week High?

How much percentage Pliant Therapeutics Inc is up from its 52 Week low?

What are the historical returns of Pliant Therapeutics Inc?

Who is the Chief Executive Officer (CEO) of Pliant Therapeutics Inc?

Trading and brokerage services provided by

Banking and Remittance services provided by

Technology services provided by : Finzoomers Services Private Limited

Disclaimer: These services are not for exchange traded products.The securities quoted are exemplary and not recommendatory. Please be informed that US Stocks are not exchange traded funds in India and Finzoomers Services Private Limited acts in the capacity of facilitator of this product. All disputes with respect to the transaction facilitation services, would not have access to Indian Exchange investor redressal forum or Arbitration mechanism in India. T&C apply*